ANCOVA results indicated that after controlling for the differences in cystatin C between PAD and non-PAD patients, the differences in ABI (F = 328.179 (1291), p = 0.000) between groups remained significant (partial eta square 0.53). This evidence concerns the gene CST3 and peripheral arterial disease.